Dark
Light
System
Institutional Investment Manager
Tekla Capital Management LLC
Tekla Capital Management LLC (CIK: 0001300336) incorporated in Delaware, located at 100 Federal Street, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q1)
Portfolio Summary: 140 holdings with a total value of $2,351,367,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ABBVIE INC 156 9,000 0.00%
2 ZAFGEN INC COM 13,307 89,000 0.00%
3 RMR GROUP INC 7,441 186,000 0.01%
4 XENCOR INC COM 20,000 268,000 0.01%
5 CELLDEX THERAPEUTICS INC NEW 105,800 400,000 0.02%
6 GENMARK DIAGNOSTICS INC. 93,349 492,000 0.02%
7 BELLICUM PHARMACEUTICALS INCORPORATED 60,000 561,000 0.02%
8 REVANCE THERAPEUTICS INC COM 45,000 786,000 0.03%
9 GALAPAGOS NV 20,000 836,000 0.04%
10 TETRAPHASE PHARMACEUTICALS INC COM 192,322 890,000 0.04%
11 CIDARA THERAPEUTICS INC 72,500 921,000 0.04%
12 AFFIMED N V COM 294,213 1,100,000 0.05%
13 ALLIQUA BIOMEDICAL INC 1,650,000 1,353,000 0.06%
14 MOMENTA PHARMACEUTICALS INC 153,700 1,420,000 0.06%
15 CHIMERIX INC 308,892 1,578,000 0.07%
16 Esperion Therapeutics Inc 102,800 1,738,000 0.07%
17 NOVAVAX INC COM 358,000 1,847,000 0.08%
18 KITE PHARMA INCORPORATED 41,000 1,882,000 0.08%
19 HALOZYME THERAPEUTICS INC 200,000 1,894,000 0.08%
20 BLUEBIRD BIO INC COM 49,345 2,097,000 0.09%
21 DBV TECHNOLOGIES S A 65,600 2,135,000 0.09%
22 CYNAPSUS THERAPEUTICS INC 180,407 2,147,000 0.09%
23 AMICUS THERAPEUTICS INC COM 258,000 2,180,000 0.09%
24 MERRIMACK PHARMACEUTI 1,485,000 2,205,000 0.09% PRN
25 INSMED INC 178,600 2,263,000 0.10%
26 CARE CAP PPTYS INC 84,316 2,263,000 0.10%
27 ALLSCRIPTS HEALTHCARE SOLUTN 173,600 2,293,000 0.10%
28 FORWARD PHARMA A/S 136,547 2,321,000 0.10%
29 FLEX PHARMA INC COM 212,600 2,332,000 0.10%
30 LEXICON PHARMACEUTICALS INC 197,641 2,362,000 0.10%
31 ADAPTIMMUNE THERAPEUTICS PLC 296,934 2,414,000 0.10%
32 GRIFOLS S A SP ADR REP B 166,000 2,568,000 0.11%
33 CELATOR PHARMACEUTICALS INC 236,000 2,603,000 0.11%
34 ARCA BIOPHARMA INCORPORATED COM PAR .001 811,227 2,783,000 0.12%
35 DEPOMED INC 200,000 2,786,000 0.12%
36 NEVRO CORP COM 49,800 2,802,000 0.12%
37 IMMUNOMEDICS INC 4,000,000 2,810,000 0.12% PRN
38 UNIQURE NV 241,021 2,863,000 0.12%
39 AURIS MED HLDG AG 834,263 3,037,000 0.13%
40 BEIGENE LTD 116,707 3,421,000 0.15%
41 SAGENT PHARMACEUTICALS INC 286,650 3,489,000 0.15%
42 INOTEK PHARMACEUTICALS CORP 487,392 3,607,000 0.15%
43 ACCELERATE DIAGNOSTICS INC 264,625 3,803,000 0.16%
44 IMPAX LABORATORIES INC 124,335 3,981,000 0.17%
45 VALEANT PHARMACEUTICALS INTL 158,000 4,155,000 0.18%
46 HERON THERAPEUTICS INC COM 219,000 4,159,000 0.18%
47 CYTOMX THERAPEUTICS INC COM 328,059 4,232,000 0.18%
48 KARYOPHARM THERAPEUTICS INC COM 500,324 4,463,000 0.19%
49 RETROPHIN INC 329,949 4,507,000 0.19%
50 ALLERGAN PLC 5,000 4,596,000 0.20%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-119071, filed 2016.05.09).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.